| Transfer of mitochondria from astrocytes to neurons after stroke K Hayakawa, E Esposito, X Wang, Y Terasaki, Y Liu, C Xing, X Ji, EH Lo Nature 535 (7613), 551-555, 2016 | 1080 | 2016 |
| Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine1A Receptor–Dependent Mechanism K Mishima, K Hayakawa, K Abe, T Ikeda, N Egashira, K Iwasaki, ... Stroke 36 (5), 1071-1076, 2005 | 229 | 2005 |
| Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury JH Seo, N Miyamoto, K Hayakawa, LDD Pham, T Maki, C Ayata, KW Kim, ... The Journal of clinical investigation 123 (2), 2013 | 201 | 2013 |
| Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery K Hayakawa, LDD Pham, ZS Katusic, K Arai, EH Lo Proceedings of the National Academy of Sciences 109 (19), 7505-7510, 2012 | 198 | 2012 |
| Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice K Hayakawa, T Nakano, K Irie, S Higuchi, M Fujioka, K Orito, K Iwasaki, ... Journal of Cerebral Blood Flow & Metabolism 30 (4), 871-882, 2010 | 195 | 2010 |
| Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism K Hayakawa, K Mishima, M Hazekawa, K Sano, K Irie, K Orito, T Egawa, ... Brain research 1188, 157-164, 2008 | 177 | 2008 |
| Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke K Hayakawa, J Qiu, EH Lo Annals of the New York Academy of Sciences 1207 (1), 50-57, 2010 | 175 | 2010 |
| Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1–inhibiting mechanism K Hayakawa, K Mishima, M Nozako, M Hazekawa, S Mishima, M Fujioka, ... Stroke 39 (3), 951-958, 2008 | 175 | 2008 |
| Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-β signaling JH Seo, T Maki, M Maeda, N Miyamoto, AC Liang, K Hayakawa, ... PloS one 9 (7), e103174, 2014 | 159 | 2014 |
| Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice N Miyamoto, T Maki, LDD Pham, K Hayakawa, JH Seo, ET Mandeville, ... Stroke 44 (12), 3516-3521, 2013 | 146 | 2013 |
| Cellular mechanisms of neurovascular damage and repair after stroke K Arai, J Lok, S Guo, K Hayakawa, C Xing, EH Lo Journal of child neurology 26 (9), 1193-1198, 2011 | 141 | 2011 |
| Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells K Hayakawa, LDD Pham, AT Som, BJ Lee, S Guo, EH Lo, K Arai Journal of Neuroscience 31 (29), 10666-10670, 2011 | 141 | 2011 |
| Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury YK Choi, T Maki, ET Mandeville, SH Koh, K Hayakawa, K Arai, YM Kim, ... Nature medicine 22 (11), 1335-1341, 2016 | 138 | 2016 |
| ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion M Fujioka, K Hayakawa, K Mishima, A Kunizawa, K Irie, S Higuchi, ... Blood, The Journal of the American Society of Hematology 115 (8), 1650-1653, 2010 | 135 | 2010 |
| Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT) 2A receptors in the prefrontal cortex N Egashira, K Iwasaki, A Ishibashi, K Hayakawa, R Okuno, M Abe, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (6), 1516-1520, 2008 | 128 | 2008 |
| Neuroprotective effect of γ-glutamylethylamide (theanine) on cerebral infarction in mice N Egashira, K Hayakawa, K Mishima, H Kimura, K Iwasaki, M Fujiwara Neuroscience letters 363 (1), 58-61, 2004 | 124 | 2004 |
| Injury and repair in the neurovascular unit C Xing, K Hayakawa, J Lok, K Arai, EH Lo Neurological research 34 (4), 325-330, 2012 | 122 | 2012 |
| Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases T Maki, K Hayakawa, LDD Pham, C Xing, EH Lo, K Arai CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2013 | 121 | 2013 |
| Repeated treatment with cannabidiol but not Δ9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance K Hayakawa, K Mishima, M Nozako, A Ogata, M Hazekawa, AX Liu, ... Neuropharmacology 52 (4), 1079-1087, 2007 | 119 | 2007 |
| Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury LDD Pham, K Hayakawa, JH Seo, MN Nguyen, AT Som, BJ Lee, S Guo, ... Glia 60 (6), 875-881, 2012 | 117 | 2012 |
Changhong XingMGH, HarvardVerified email at mgh.harvard.edu
